Final ID: 161
Topjian Alexis, Kanthimathinathan Hari, Guerguerian Anne-marie, Slomine Beth, Nadkarni Vinay, George Shane, Silbergleit Robert, Weber Monica, Moler Frank, Meurer William, Yeatts Sharon, Page Kent, Vanburen John, Kirschen Matthew, Meert Kathleen, Silverstein F, Berg Robert
Plasma Glutamate, Early Neurological Risk Stratification, and Outcome: A Post-hoc Analysis of the PROTECT TrialRiker Richard, Ryzhov Sergey, Dekay Joanne, May Teresa, Weissman Alexandra, Callaway Clifton, Sawyer Douglas, Seder David B., Gagnon David
We encourage you to enter the discussion by posting your comments and questions below.
Presenters will be notified of your post so that they can respond as appropriate.
This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.
You have to be authorized to post a comment. Please, Login or Signup.